Venture Life Group PLC (LSE:VLG), a prominent UK-based player in the global consumer healthcare space, has issued a notice of a general meeting to shareholders, coinciding with the publication of its Annual Report for the year ended December 2024. The meeting is set to take place on 5 August 2025 in London, shortly after the company’s Annual General Meeting, which occurred on 30 June 2025.
In addition, Venture Life will host an investor presentation on 3 July 2025, led by CEO Jerry Randall and CFO Daniel Wells. The session will cover the company’s full-year results and is open to both current and prospective shareholders. Attendees will have the opportunity to submit questions ahead of time or participate live during the event, reinforcing the company’s commitment to transparency and shareholder engagement.
About Venture Life Group
Venture Life is an international self-care company focused on developing and marketing a wide range of consumer healthcare products. Its portfolio features well-known brands such as Balance Activ for women’s intimate health, Earol for ear, nose, and throat care, Lift and Glucogel for energy and glucose support, and the Health and Her range designed to support women through hormonal transitions. Products are distributed via major health and beauty chains, pharmacies, supermarkets, and online platforms, with a strong presence in the UK, Ireland, the USA, and through global distribution partnerships.
Leave a Reply